Approval · Notice of Compliance 10144 · 2009
AMPROL: Notice of Compliance 10144
Issued April 9, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10144
- Date
- April 9, 2009
- Company
- Huvepharma EoodSofia, Sofia, Bulgaria
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in ownership
- Therapeutic class
- Anticoccidial
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AMPROL | 00140481 | Marketed |
Medicinal ingredients
- AMPROLIUM 9.6 PER